Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138214 · ClinicalTrials.gov registry record · Phase 2
Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer
A Phase 2 study of Stage I Papillary Thyroid Cancer and Stage II Papillary Thyroid Cancer, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT02138214 is a Phase 2 study of Stage I Papillary Thyroid Cancer and Stage II Papillary Thyroid Cancer that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 117 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02138214, a Phase 2 study of Stage I Papillary Thyroid Cancer and Stage II Papillary Thyroid Cancer, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies how well thyroid gland removal with or without central lymph node dissection works in treating patients with thyroid cancer or suspected thyroid cancer that has not spread to the lymph nodes (randomized into Arms I and II). Arms I and II are compared to a standard of care (SOC) Arm III to enable comparison of quality of life among various surgical treatments. Currently, the standard treatment for thyroid cancer is total thyroidectomy, or complete removal of the thyroid. The lymph nodes in the central part of the neck may also be surgically removed, called central lymph node dissection. Prophylactic removal of the lymph nodes may increase the risk of life-threatening complications, and may reduce post-surgery quality of life. It may also prevent the cancer from returning and reduce the need for additional surgery. It is not yet known whether recurrence rates and complication levels are lower after thyroid gland removal alone or with central lymph node dissection.
Conditions Studied
Interventions
- PROCEDURE Thyroidectomy
- PROCEDURE entral lymph node dissection (CLND)
- OTHER Quality-of-life assessment
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2014-06-06 |
| Est. Completion | 2020-10-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02138214
The ClinicalTrials.gov registry entry for NCT02138214 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stage I Papillary Thyroid Cancer appearing as the primary indexed condition, and to 3 interventions - of which Thyroidectomy is the first listed.
NCT02138214 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02138214 about?
NCT02138214 is a clinical study titled "Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer". This phase II trial studies how well thyroid gland removal with or without central lymph node dissection works in treating patients with thyroid cancer or suspected thyroid cancer that has not spread to the lymph nodes (randomized into Arms I and II). Arms I and II are compared to a standard of care...
What is the current status of trial NCT02138214?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 117 participants. The study started on 2014-06-06. Estimated completion is 2020-10-26.
What conditions does trial NCT02138214 study?
This clinical trial studies the following conditions: Stage I Papillary Thyroid Cancer, Stage II Papillary Thyroid Cancer, Stage III Papillary Thyroid Cancer.
What interventions are being tested in trial NCT02138214?
The interventions under investigation include: Thyroidectomy (PROCEDURE), entral lymph node dissection (CLND) (PROCEDURE), Quality-of-life assessment (OTHER).
Who is sponsoring clinical trial NCT02138214?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02138214 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Stage I Papillary Thyroid Cancer
All registered trials for this condition
Stage II Papillary Thyroid Cancer
All registered trials for this condition
Wisconsin
All trials with a study site in Wisconsin
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.